We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Tuberculosis Global Clinical Trials Review, H2, 2018

Published: September 2018
Pages: 472
Code: 6BA05D6DF342E55CCAD7A59110679649
Format: PDF
Publisher GlobalData
From Add to basket
$ 2,500.00
GlobalData's clinical trial report, “ provides an overview of Tuberculosis clinical trials scenario. This report provides top line data relating to the clinical trials on Tuberculosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Additonal Information

  • - The report provides a snapshot of the global clinical trials landscape
  • - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • - The Report provides enrollment trends for the past five years
  • - Report provides latest news for the past three months
  • *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies Mentioned

Johnson & Johnson
Wellcome Trust
GlaxoSmithKline Plc
Macleods Pharmaceuticals Ltd
Otsuka Holdings Co Ltd
Sanofi
Pfizer Inc
Sequella Inc
IQVIA Holdings Inc
Merck & Co Inc

Reasons to buy

Assists in formulating key business strategies with regards to investment Helps in identifying prominent locations for conducting clinical trials which saves time and cost Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities Supports understanding of trials count and enrollment trends by country in global therapeutics market Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials Facilitates clinical trial assessment of the indication on a global, regional and country level *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Add to basket
  • Table of Contents
  • Table of Contents 2
  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Top Five Countries Contributing to Clinical Trials in Central and South America 15
  • Clinical Trials by G7 Countries: Proportion of Tuberculosis to Infectious Disease Clinical Trials 16
  • Clinical Trials by Phase in G7 Countries 18
  • Clinical Trials in G7 Countries by Trial Status 19
  • Clinical Trials by E7 Countries: Proportion of Tuberculosis to Infectious Disease Clinical Trials 21
  • Clinical Trials by Phase in E7 Countries 23
  • Clinical Trials in E7 Countries by Trial Status 24
  • Clinical Trials by Phase 26
  • In Progress Trials by Phase 27
  • Clinical Trials by Trial Status 28
  • Clinical Trials by End Point Status 30
  • Subjects Recruited Over a Period of Time 31
  • Clinical Trials by Sponsor Type 32
  • Prominent Sponsors 33
  • Top Companies Participating in Tuberculosis Therapeutics Clinical Trials 35
  • Prominent Drugs 37
  • Latest Clinical Trials News on Tuberculosis 38
  • Jul 11, 2018: New England Journal of Medicine Publishes Final Results from Innovative Phase 2 Study Showing Vaccines Can Reduce Rate of Sustained TB Infections in Adolescents at High Risk 38
  • Clinical Trial Profile Snapshots 39
  • Appendix 470
  • Abbreviations 470
  • Definitions 470
  • Research Methodology 471
  • Secondary Research 471
  • About GlobalData 471
  • Contact Us 472
  • Source 472
  • List of Tables
  • Tuberculosis Therapeutics, Global, Clinical Trials by Region, 2018* 7
  • Tuberculosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
  • Tuberculosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
  • Tuberculosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11
  • Tuberculosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
  • Tuberculosis Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
  • Tuberculosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 14
  • Tuberculosis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018* 15
  • Proportion of Tuberculosis to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 17
  • Tuberculosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
  • Tuberculosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 20
  • Proportion of Tuberculosis to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 22
  • Tuberculosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
  • Tuberculosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 25
  • Tuberculosis Therapeutics, Global, Clinical Trials by Phase, 2018* 26
  • Tuberculosis Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 27
  • Tuberculosis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 29
  • Tuberculosis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 30
  • Tuberculosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 31
  • Tuberculosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 32
  • Tuberculosis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 34
  • Tuberculosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 36
  • Tuberculosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 37
  • List of Figures
  • Tuberculosis Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
  • Tuberculosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
  • Tuberculosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
  • Tuberculosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11
  • Tuberculosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
  • Tuberculosis Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13
  • Tuberculosis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 14
  • Tuberculosis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018* 15
  • Proportion of Tuberculosis to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 16
  • Tuberculosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 18
  • Tuberculosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 19
  • Proportion of Tuberculosis to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 21
  • Tuberculosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 23
  • Tuberculosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 24
  • Tuberculosis Therapeutics, Global, Clinical Trials by Phase (%), 2018* 26
  • Tuberculosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 27
  • Tuberculosis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 28
  • Tuberculosis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 30
  • Tuberculosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 31
  • Tuberculosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 32
  • Tuberculosis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 33
  • Tuberculosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 35
  • Tuberculosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 37
  • GlobalData Methodology 471

Keywords
;